Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 76Viral Infectious Diseases and Gene Expression in InsectsFluid Dynamics and MixingProtein purification and stability

The DOI matches its Crossref record; the references it cites are not checked yet.

Combined metabolomics and proteomics reveals hypoxia as a cause of lower productivity on scale-up to a 5000-liter CHO bioprocess

Abstract

Large-scale bioprocessing is key to the successful manufacturing of a biopharmaceutical. However, cell viability and productivity are often lower in the scale-up from laboratory to production. In this study, we analyzed CHO cells, which showed lower percent viabilities and productivity in a 5-KL production scale bioreactor compared to a 20-L bench-top scale under seemingly identical process parameters. An increase in copper concentration in the media from 0.02 µM to 0.4 µM led to a doubling of percent viability in the production scale albeit still at a lower level than the bench-top scale. Combined metabolomics and proteomics revealed the increased copper reduced the presence of reactive oxygen species (ROS) in the 5-KL scale process. The reduction in oxidative stress was supported by the increased level of glutathione peroxidase in the lower copper level condition. The excess ROS was shown to be due to hypoxia (intermittent), as evidenced by the reduction in fibronectin with increased copper. The 20-L scale showed much less hypoxia and thus less excess ROS generation, resulting in little to no impact to productivity with the increased copper in the media. The study illustrates the power of 'Omics in aiding in the understanding of biological processes in biopharmaceutical production.

Overview

Integrity signals

Registry

Crossref · 10.1002/biot.201600030

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists haven’t been fetched yet

References 59 · Cited by 76

Research works printed but not linked: 1

  1. 10.1074/jbc.M110.217216 · DOI

Metadata

Authors
Gao, Y., Ray, S., Dai, S., Ivanov, A. R., Abu‐Absi, N. R., Lewis, A. M., Huang, Z., Xing, Z., Borys, M. C., Li, Z. J., & Karger, B. L.
Affiliations
  • Northeastern University (US)
  • Bristol-Myers Squibb (United States) (US)
Corresponding author
Karger, Barry L.
Venue
Biotechnology Journal
Publisher
Wiley
Published
2016-06-29
Volume
11
Issue
9
Pages
1190-1200
ISSN
  • 1860-6768 (ISSN-L)
  • 1860-7314
OpenAlex
W2401202998
Cited by
76
References
59
Citations by year
2026: 2 · 2025: 9 · 2024: 8 · 2023: 9 · 2022: 4 · 2021: 11 · 2020: 9 · 2019: 5 · 2018: 12 · 2017: 6 · 2016: 1
FWCI
4.16
Type
journal article
Language
en
Open access
closed
Locations
  • Biotechnology Journal (publishedVersion)
  • PubMed (publishedVersion)
Funders
Bristol-Myers Squibb
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
  • Physical Sciences › Chemical Engineering › Fluid Flow and Transfer Processes › Fluid Dynamics and Mixing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
Keywords
CHO cells, hypoxia, scale-up, biopharmaceutical manufacturing, copper content, reactive oxygen species, oxidative stress, glutathione peroxidase, fibronectin, cell viability, metabolomics, proteomics
MeSH terms
Animals, Cell Survival, Copper, Cricetulus, Fibronectins, Humans, Cell Hypoxia, CHO Cells, Reactive Oxygen Species, Bioreactors, Proteomics, Cell Proliferation, Metabolomics, Batch Cell Culture Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Combined metabolomics and proteomics reveals hypoxia as a cause of lower productivity on scale-up to a 5000-liter CHO bioprocess. https://app.cochat.ai/papers/10.1002/biot.201600030
The paper
Gao, Y., Ray, S., Dai, S., Ivanov, A. R., Abu‐Absi, N. R., Lewis, A. M., Huang, Z., Xing, Z., Borys, M. C., Li, Z. J., & Karger, B. L. (2016). Combined metabolomics and proteomics reveals hypoxia as a cause of lower productivity on scale-up to a 5000-liter CHO bioprocess. Biotechnology Journal. https://doi.org/10.1002/biot.201600030

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.